Adma Biologics Inc’s recent filing unveils that its CFO and Treasurer Tade Brad L. unloaded Company’s shares for reported $0.32 million on Nov 22 ’24. In the deal valued at $21.15 per share,15,000 shares were sold. As a result of this transaction, Tade Brad L. now holds 199,433 shares worth roughly $3.53 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Grossman Adam S sold 48,967 shares, generating $1,033,204 in total proceeds. Upon selling the shares at $21.10, the President and CEO now owns 1,989,007 shares.
Before that, Grossman Adam S bought 48,967 shares. Adma Biologics Inc shares valued at $1,042,997 were divested by the Director and Officer at a price of $21.30 per share.
A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Raymond James also remained covering ADMA and has increased its forecast on November 11, 2021 with a “Strong buy” recommendation from previously “an Outperform” rating. Cantor Fitzgerald started covering the stock on November 09, 2021. It rated ADMA as “an Overweight”.
Price Performance Review of ADMA
On Monday, Adma Biologics Inc [NASDAQ:ADMA] saw its stock jump 1.84% to $17.72. Over the last five days, the stock has lost -6.64%. Adma Biologics Inc shares have risen nearly 292.04% since the year began. Nevertheless, the stocks have risen 329.06% over the past one year. While a 52-week high of $23.64 was reached on 11/11/24, a 52-week low of $4.07 was recorded on 01/03/24. SMA at 50 days reached $18.84, while 200 days put it at $13.64.
Levels Of Support And Resistance For ADMA Stock
The 24-hour chart illustrates a support level at 17.36, which if violated will result in even more drops to 16.99. On the upside, there is a resistance level at 17.98. A further resistance level may holdings at 18.23. The Relative Strength Index (RSI) on the 14-day chart is 39.83, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.08, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 78.08%. Stochastics %K at 17.51% indicates the stock is a buying.
How much short interest is there in Adma Biologics Inc?
A steep rise in short interest was recorded in Adma Biologics Inc stocks on 2024-11-29, dropping by -2.29 million shares to a total of 12.91 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 15.2 million shares. There was a decline of -17.76%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on June 04, 2019 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.
